QLSF Biotherapeutics
- Biotech or pharma, therapeutic R&D
*We are not accepting meetings with CROs, CMOs, and consultants*
QLSF Biotherapeutics is a clinical-stage biotechnology company dedicated to revolutionizing cancer treatment through innovative immuno-oncology therapies. We are seeking out-licensing the following assets:
- PD-L1 x 4-1BB bispecific in phase 2 for solid tumors
- CLEC12A x CD3 TCE in phase 1 for AML
- LY6G6D x CD3 TCE in phase 1 for CRC
- PSMA x CD3 x CD2 TCE in IND enabling for CRPC
- EGFR x MET x CD3 x CD2 in DC stage for solid tumors
Address
South San FranciscoCalifornia
United States
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}